Clinical trial
Growth Hormone to Increase Immune Function in People With HIV
NCT00071240 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00071240 |
|---|---|
| Title | Growth Hormone to Increase Immune Function in People With HIV |
| Official title | The Use of Recombinant Growth Hormone to Enhance T-Cell Production in Adults Infected With HIV-1 |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | The J. David Gladstone Institutes University of California, San Francisco National Center for Research Resources (NCRR) NIH EMD Serono Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Somatropin (recombinant human growth hormone) |
| Enrollment | 22 |
| Start date | Oct 1, 2002 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Oct 17, 2003 |
| Last update posted | Aug 17, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: